CNA Financial Corporation (CNA)
NYSE: CNA
· Real-Time Price · USD
47.85
0.14 (0.29%)
At close: Aug 15, 2025, 12:39 PM
CNA Financial Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 14.52B | 14.32B | 14.19B | 14.02B | 13.74B | 13.47B | 13.15B | 12.96B | 12.78B | 12.45B | 9.35B | 9.15B | 8.96B | 9.06B | 11.91B | 11.79B | 11.65B | 11.38B |
Cost of Revenue | 5.35B | 5.73B | 3.23B | 740M | 716M | 684M | 684M | 1.03B | 1.04B | 1.02B | 1.02B | 675M | 616M | 590M | 590M | 711M | 693M | 674M |
Gross Profit | 5.45B | 8.59B | 10.96B | 13.28B | 13.02B | 12.79B | 12.47B | 11.93B | 11.74B | 11.43B | 8.32B | 8.47B | 8.34B | 8.47B | 11.32B | 11.07B | 10.95B | 10.71B |
Operating Income | 1.21B | 1.23B | 1.31B | 1.34B | 1.14B | 648M | 186M | 342M | 551M | 859M | 1.26B | 1.42B | 1.36B | 1.6B | 1.6B | 1.75B | 1.69B | 1.41B |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 1.11B | 1.13B | 1.21B | 1.65B | 1.61B | 1.57B | 1.52B | 1.42B | 1.46B | 1.35B | 1.35B | 1.32B | 1.27B | 1.48B | 1.48B | 1.63B | 1.57B | 1.29B |
Net Income | 877M | 895M | 959M | 1.3B | 1.28B | 1.25B | 1.21B | 1.09B | 1.13B | 1.05B | 1.06B | 1.08B | 1.04B | 1.2B | 1.2B | 1.32B | 1.28B | 1.06B |
Selling & General & Admin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 6.46B | 5.25B | 4.08B | -2.9B | -8.58B | -10.33B | -6.03B | -5.39B | -5.33B | -3.45B | -6.19B | -6.13B | -5.71B | -6.87B | -9.72B | -9.33B | -9.27B | -9.3B |
Operating Expenses | 6.46B | 7.66B | 8.83B | 1.85B | -3.82B | -7.98B | -6.03B | -5.39B | -5.33B | 292M | -2.45B | -2.39B | -1.97B | -6.87B | -9.72B | -9.33B | -9.27B | -9.3B |
Interest Expense | 127M | 130M | 133M | 135M | 137M | 134M | 127M | 121M | 115M | 112M | 112M | 112M | 112M | 113M | 113M | 113M | 117M | 119M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 10.04B | 6.96B | 752M | 141M | -74M | 5.9B | 12.01B | 11.91B | 11.68B | 11.48B | 10.86B | 10.69B | 10.56B | 10.44B | 10.42B | 10.15B | 10.08B | 10.1B |
Income Tax Expense | -78M | 88M | 252M | 345M | 335M | 328M | 313M | 298M | 304M | 266M | 257M | 243M | 227M | 281M | 282M | 309M | 288M | 225M |
Shares Outstanding (Basic) | 271.1M | 271.3M | 271.3M | 271.3M | 271.6M | 271.6M | 271.3M | 271.2M | 271.2M | 272.3M | 271.3M | 271.4M | 271.7M | 271.8M | 271.7M | 271.7M | 271.9M | 271.9M |
Shares Outstanding (Diluted) | 272.2M | 272.6M | 272.9M | 272.7M | 272.6M | 272.7M | 272.2M | 272.3M | 272M | 272.3M | 272M | 272.3M | 272.6M | 272.9M | 272.9M | 272.7M | 272.8M | 272.9M |
EPS (Basic) | 3.23 | 3.30 | 3.53 | 4.80 | 4.71 | 4.58 | 4.43 | 4.12 | 4.26 | 3.92 | 3.98 | 3.92 | 3.77 | 4.42 | 4.42 | 4.86 | 4.71 | 3.92 |
EPS (Diluted) | 3.22 | 3.28 | 3.52 | 4.79 | 4.70 | 4.58 | 4.43 | 4.12 | 4.26 | 3.91 | 3.97 | 3.91 | 3.76 | 4.42 | 4.41 | 4.85 | 4.70 | 3.90 |
EBITDA | 479M | 933M | 1.41B | 1.86B | 1.83B | 1.78B | 1.72B | 1.53B | 1.14B | 1B | 1.01B | 1.05B | 1.41B | 1.65B | 1.65B | 1.8B | 1.74B | 1.47B |
EBIT | 827M | 1.26B | 1.34B | 1.78B | 1.75B | 1.71B | 1.65B | 1.47B | 1.09B | 953M | 960M | 996M | 1.36B | 1.6B | 1.6B | 1.75B | 1.69B | 1.41B |
Depreciation & Amortization | 33M | 51M | 67M | 80M | 79M | 77M | 73M | 57M | 54M | 50M | 51M | 51M | 52M | 53M | 54M | 55M | 56M | 58M |